Cynata Therapeutics Ltd has released a press release.
DSMB Recommends Continuation of Cynatas MEND Trial
Filed with ASX ·
6ix hasn’t read this filing yet.
Cynata Therapeutics Limited on 6ix
Earlier from Cynata Therapeutics
- Cynata Enters into a New Strategic Partnership with Fujifilm
- Further Patents for Cynata Unique Cymerus Technology
- Further Canadian Patent for Cynata
- Cynata Receives Notice of Allowance from US Patent Office
- Ethics Approval for Cynatas Clinical Trial in DFU
Later from Cynata Therapeutics
- Cynata Receives US$5m Fujifilm Fee
- Site Initiation Visit Completed for CYP DFU Clinical Trial
- Cynata Commences DFU Clinical Trial
- FUJIFILM Cellular Dynamics Executes Manufacturing Agreement
- Cynata Receives Decision to Grant a Patent in Japan
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics